BRD4 anticorps (N-Term)
-
- Antigène Voir toutes BRD4 Anticorps
- BRD4 (Bromodomain Containing 4 (BRD4))
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BRD4 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
- Specificité
- Brd4 Antibody detects endogenous levels of total Brd4.
- Homologie
- Pig,Zebrafish,Bovine,Horse,Sheep,Dog,Chicken
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogène
- A synthesized peptide derived from human Brd4, corresponding to a region within N-terminal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product BRD4 Anticorps primaire
-
-
- Indications d'application
- WB 1:1000-3000, IHC 1:200, IF/ICC, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
- Date de péremption
- 12 months
-
- Antigène
- BRD4 (Bromodomain Containing 4 (BRD4))
- Autre désignation
- BRD4 (BRD4 Produits)
- Synonymes
- anticorps brd4-b, anticorps BRD4, anticorps fb18g03, anticorps wu:fb18g03, anticorps CAP, anticorps HUNK1, anticorps HUNKI, anticorps MCAP, anticorps Brd5, anticorps WI-11513, anticorps bromodomain containing 4 L homeolog, anticorps bromodomain containing 4, anticorps bromodomain-containing protein 4, anticorps brd4.L, anticorps BRD4, anticorps brd4, anticorps LOC100409351, anticorps Brd4
- Sujet
-
Description: Chromatin reader protein that recognizes and binds acetylated histones and plays a key role in transmission of epigenetic memory across cell divisions and transcription regulation. Remains associated with acetylated chromatin throughout the entire cell cycle and provides epigenetic memory for postmitotic G1 gene transcription by preserving acetylated chromatin status and maintaining high-order chromatin structure. During interphase, plays a key role in regulating the transcription of signal-inducible genes by associating with the P-TEFb complex and recruiting it to promoters: BRD4 is required to form the transcriptionally active P-TEFb complex by displacing negative regulators such as HEXIM1 and 7SKsnRNA complex from P-TEFb, thereby transforming it into an active form that can then phosphorylate the C-terminal domain (CTD) of RNA polymerase II. Promotes phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II. According to a report, directly acts as an atypical protein kinase and mediates phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA polymerase II, these data however need additional evidences in vivo (PubMed:22509028). In addition to acetylated histones, also recognizes and binds acetylated RELA, leading to further recruitment of the P-TEFb complex and subsequent activation of NF-kappa-B. Also acts as a regulator of p53/TP53-mediated transcription: following phosphorylation by CK2, recruited to p53/TP53 specific target promoters.
Gene: BRD4
- Poids moléculaire
- 152kDa
- ID gène
- 23476
- UniProt
- O60885
- Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interactome
-